Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Angiotensin II Type 2 Receptor Blockers

Known as: Type 2 Angiotensin Receptor Antagonists, Type 2 Angiotensin Receptor Blockers, Angiotensin 2 Receptor Antagonists 
Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
  • A. Bock
  • Therapeutische Umschau. Revue therapeutique
  • 2018
  • Corpus ID: 81984316
Antihypertensive therapy in chronic kidney disease: what targets and how to reach them Abstract. The primary treatment target for… Expand
Review
2015
Review
2015
OBJECTIVES Optimising secondary prevention of cardiovascular disease has the greatest potential to reduce recurrent events, yet… Expand
  • figure 1
Review
2015
Review
2015
Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) constitute first line treatment for… Expand
2013
2013
The importance of the (pro)renin receptor (PRR) in the function of the central nervous system is increasingly evident because PRR… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2013
Review
2013
Background:  Antihypertensive medicines are to known to cause diverse disturbances to electrolyte homeostasis; however, their… Expand
2006
2006
  • Nature Clinical Practice Rheumatology
  • 2006
  • Corpus ID: 19881621
was positively correlated with insulin resistance and with impaired beta-cell function. The authors suggest that increased… Expand
2005
2005
 
Review
2003
Review
2003
The International Diabetes Federation (Europe) has updated these guidelines on hypertension management specifically in Type 2… Expand
Review
2003
Review
2003
Diabetic nephropathy is characterized by increased urinary albumin excretion and loss of renal function. Increased urinary… Expand